miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers

Extracellular vesicles (EVs) are shed by many different cell types. Their nucleic acids content offers new opportunities for biomarker research in different solid tumors. The role of EV RNA in prostate cancer (PCa) is still largely unknown. EVs were isolated from different benign and malignant prost...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2019-12, Vol.12 (1), p.43
Main Authors: Worst, Thomas Stefan, Previti, Christopher, Nitschke, Katja, Diessl, Nicolle, Gross, Julia Christina, Hoffmann, Lena, Frey, Lisa, Thomas, Vanessa, Kahlert, Christoph, Bieback, Karen, Crigna, Adriana Torres, Fricke, Fabia, Porubsky, Stefan, Westhoff, Niklas, Hardenberg, Jost von, Nuhn, Philipp, Erben, Philipp, Michel, Maurice Stephan, Boutros, Michael
Format: Article
Language:English
Subjects:
Biomarkers
Cell culture
Electron microscopy
Flow cytometry
Hyperplasia
Metastases
Metastasis
miRNA
Nanoparticles
Next-generation sequencing
Non-coding RNA
Prostate cancer
Proteins
Solid tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Extracellular vesicles (EVs) are shed by many different cell types. Their nucleic acids content offers new opportunities for biomarker research in different solid tumors. The role of EV RNA in prostate cancer (PCa) is still largely unknown. EVs were isolated from different benign and malignant prostate cell lines and blood plasma from patients with PCa ( = 18) and controls with benign prostatic hyperplasia (BPH) ( = 7). Nanoparticle tracking analysis (NTA), Western blot, electron microscopy, and flow cytometry analysis were used for the characterization of EVs. Non-coding RNA expression profiling of PC3 metastatic PCa cells and their EVs was performed by next generation sequencing (NGS). miRNAs differentially expressed in PC3 EVs were validated with qRT-PCR in EVs derived from additional cell lines and patient plasma and from matched tissue samples. 92 miRNAs were enriched and 48 miRNAs were depleted in PC3 EVs compared to PC3 cells, which could be confirmed by qRT-PCR. miR-99b-5p was significantly higher expressed in malignant compared to benign EVs. Furthermore, expression profiling showed miR-10a-5p ( = 0.018) and miR-29b-3p ( = 0.002), but not miR-99b-5p, to be overexpressed in plasma-derived EVs from patients with PCa compared with controls. In the corresponding tissue samples, no significant differences in the miRNA expression could be observed. We thus propose that EV-associated miR-10a-5p and miR-29b-3p could serve as potential new PCa detection markers.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers12010043